The addition of β-adrenergic receptor antagonists to a medical regimen for ... Adapted from McMurray JJV. Major beta blocker mortality trials in chronic heart failure: a critical review.

Beta-blockers antagonize beta-1 and beta-2 receptors which are the usual targets of the sympathetic nervous system, including epinephrine and norepinephrine. This results in a decreased heart rate ...

The Cleveland Clinic classified beta blockers into two categories, cardioselective and nonselective, according to its website. The latter is for medicines that block the B1 receptors found in the ...

Beta blockers act by blocking the β-receptors of the sympathetic nervous system, some specifically on β-receptors in the heart, and, in doing so, decrease the heart rate and blood pressure.

Propranolol reduces Parkinson’s tremor and motor cortex activity, suggesting a new therapeutic approach beyond stress ...

Beta-blockers are thought to cause “unopposed alpha receptor agonism.” Since the beta receptors would be occupied by the beta-blockers, substances (epinephrine, norepinephrine, etc.) ...